Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference

Press release content from Accesswire. The AP news staff was not involved in its creation.

Related Keywords

Geneva ,Genè ,Switzerland ,Nevada ,United States ,Swiss ,Jim Denike ,Michael Miller ,Raghuram Ram Selvaraju ,Las Vegas ,Jack Weinstein ,Advita Lifescience Gmb ,Pharma Research ,Genetic Metabolic Dieticians International ,Drug Administration ,Swiss Exchange ,Rx Communications Group ,Nasdaq ,Exchange Commission ,Relief Therapeutics Holdings ,University Of Washington ,European Medicines Agency ,Relief Therapeutics Holding ,Acer Therapeutics Inc ,Neurorx Inc ,Acer Therapeutics ,Adrian Quartel ,Urea Cycle Disorders ,Prescription Drug User Fee Act ,Marketing Authorization Application ,Potential Alternative ,Glycerol Phenylbutyrate ,Masked Coating ,Sodium Phenylbutyrate ,Molecular Genetics ,Metabolism Reports ,Maple Syrup Urine Disease ,Vasomotor Symptoms ,License Agreement ,Vasoactive Intestinal Peptide ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Urea Cycle ,Private Securities Litigation Reform Act ,Annual Report ,Financial Officer ,Covid 19 ,Science ,Health ,Business ,Europe ,Accesswire ,